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INTRODUCTION
Strongyloides stercoralis is an intestinal nematode acquired in the 
tropics or subtropics.1-3 In an immunocompetent host, infection with 
S stercoralis produces a negligible or minimally symptomatic chronic 
disease. However, when immunosuppression impairs the host’s regu-
latory function, infection with S stercoralis can lead to hyperinfection 
syndrome and disseminated strongyloidiasis, which can be fatal. 
Diagnosing strongyloidiasis early is important because the case fatal-
ity rate of hyperinfection syndrome in immunosuppressed patients 
is between 50 and 86%.4-5 We report the case of a woman from Laos 
with recently diagnosed lupus nephritis who presented with com-
plaints of abdominal pain, vomiting, and diarrhea.
CASE REPORT
A 57-year-old Laotian female with a past medical history of sys-
temic lupus erythematosus presented as a transfer from an outside 
facility for further management of a lupus nephritis flare. She was 
admitted at the outside facility five days before transfer due to 
complaints of shortness of breath on exertion, leg swelling, inter-
mittent non-bloody watery diarrhea, nausea, vomiting, abdominal 
pain, bloating, and worsening proteinuria over two weeks. She had a 
history of lupus for the past few years. Due to worsening renal func-
tion, she had a renal biopsy three months prior to presentation which 
was consistent with lupus nephritis (stage V membranous nephropa-
thy). She was placed on prednisone taper and mycophenolate mofetil 
two months prior at the outside facility. At presentation, the patient 
reported four days of melena but denied bloody stools. She did not 
report any recent travel outside the United States, any sick contacts, 
or recent antibiotic use. 
On examination, the patient demonstrated pallor and alopecia. 
Cardiovascular and respiratory examinations were unremarkable, 
and her abdomen was soft without any tenderness or abdominal dis-
tension. Bilateral knee swelling and pedal edema were noted. Skin 
examination was normal. She had normal vital signs on admission 
at our hospital. Labs done on admission demonstrated normocytic 
anemia with hemoglobin of 9.8 gm/dl (reference range 12 - 15 gm/
dl), leukocytosis with white blood cell count of 13.3 K/UL (reference 
range 4.5 - 11.0 K/UL, differential count not checked), elevated ESR 
of 41 mm/hr (reference range 0 - 30 mm/hr), elevated CRP of 1.64 
mg/dl (reference range < 1.0 mg/dl), and normal renal and liver func-
tion tests. Urine culture was positive for Escherichia Coli, which was 
treated with appropriate antibiotics. 
Due to melena and a two-gram drop in hemoglobin, upper and 
lower endoscopy was performed. Esophagogastroduodenoscopy 
(EGD) showed a large gastric submucosal mass with the appearance 
of cystic lesion in the cardia, which was not biopsied, and erythema-
tous mucosa in the stomach and normal appearing duodenum (Figure 
1), which was biopsied due to history of watery diarrhea. Duodenal 
biopsies showed marked duodenitis with parasitic organisms favor-
ing duodenal strongyloidiasis (Figures 2, 3, and 4). Colonoscopy 
demonstrated a 4 mm cecal polyp, consistent with tubular adenoma, 
and 7 mm sigmoid colon polyp, which were removed. Colonoscopy 
also revealed normal ileum and colonic mucosa.
Following the diagnosis of duodenal strongyloidiasis by biopsy, 
the patient’s absolute eosinophil count was elevated at 1137/UL 
(reference range 0 - 450/UL). Strongyloides antibody (IgG) and 
Immunoglobin E (IgE) were positive. Stool examination was posi-
tive for Strongyloides stercoralis. Sputum examination was negative, 
as was the CT scan of the chest, providing no definite evidence of 
disseminated disease. We did not find the source of melena but hemo-
globin stabilized during the hospital stay. The patient was treated 
with 9 mg ivermectin for seven days and finally discharged on 9 mg 
ivermectin monthly for six months. 
Two weeks following discharge, the patient was readmitted with 
complaints of melena, fatigue, and abdominal pain. Stool exami-
nation was negative for S stercoralis, and peripheral eosinophilia 
had resolved. She was evaluated further with EGD for melena and 
noted to have gastric cardia submucosal mass and otherwise normal 
stomach. Duodenal biopsy obtained at that time did not show evi-
dence of parasitic organisms.
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Figure 1. Normal endoscopic appearance of the second part of the duodenum.
Figure 2. The duodenal biopsy showed a dense inflammatory infiltrate with 
eosinophils, lymphocytes, plasma cells, and few neutrophils involving and 
causing expansion of the lamina propria and shortening of the villi (hema-
toxylin and eosin stain, low power field image). 
Figure 3. Strongyloides stercoralis is identified within the crypts of the duo-
denum. Rhabditiform and filariform larvae (yellow arrow) along with adult 
females with eggs (cross section; yellow arrow head) are seen (hematoxylin 
and eosin stain, high power field image).
Figure 4. Longitudinal section of the adult Strongyloides stercoralis worm 
(yellow arrow) (hematoxylin and eosin stain, high power field image). 
DISCUSSION
Roughly 100 million people are infected by Strongyloides stercora-
lis in tropical and subtropical areas.1-3 It is the fourth most common 
nematode infection in the world and is prevalent in Africa, Asia, 
Southeast Asia, Central America, South America, and parts of the 
eastern United States. Humans acquire strongyloidiasis when larvae 
penetrate the skin and migrate to reach the duodenum and upper 
jejunum to mature. The rhabditiform larvae develop into filariform 
larvae within the intestines, which may penetrate the colonic wall or 
perianal skin and complete an internal cycle (auto-infection). This 
phenomenon of autoinfection is responsible for the persistence of 
infection virtually indefinitely in infected hosts.6-7
Chronic infection with S stercoralis is most often asymptomatic 
in an immunocompetent host.8,9 Hyperinfection syndrome mani-
festing as locally destructive bowel or lung disease and disseminated 
strongyloidiasis can occur in patients with impaired cell-mediat-
ed immunity (such as patients with transplant, patients receiving
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pulmonary symptoms are common but non-specific, and include 
abdominal pain, diarrhea, vomiting, adynamic ileus, small bowel 
obstruction (SBO) and protein-losing enteropathy, as well as pneu-
monia.10,11 Endoscopic findings of the duodenum in strongyloidiasis 
as reported by several prior case reports, includes normal mucosa, 
edema, erythema, erosion, swollen folds, fine granule, tiny ulcer, 
polyps, hemorrhage, megaduodenum, deformity, and stenosis.12
Definitive diagnosis of strongyloidiasis usually is made by detecting 
larvae in the stool, sputum, or tissue biopsy. A single stool examina-
tion is unable to detect larvae in up to 70% of cases, but repeat stool 
examinations have been shown to improve diagnostic sensitivity.13,14 
Due to the need for multiple stool samples to detect S stercoralis 
larvae, it is important to recognize that not identifying larvae in the 
stool does not imply an absence of infection. Upper and lower endos-
copy also can establish the diagnosis of strongyloidiasis, as larvae may 
be seen on biopsies of the affected mucosa as noted in our patient.15 
Thompson et al.16 showed that a minimum of six biopsies obtained 
from duodenal lesions resulted in a 100% histopathologic yield in 
diagnosing duodenal strongyloidiasis. Larvae can be demonstrated 
on normal appearing duodenal mucosa as shown in our patients and 
the endoscopist should consider biopsy of normal appearing duode-
num if there is clinical suspicion of Strongyloides infection.
Ivermectin is the drug of choice as per World Health Organiza-
tion.13 In disseminated disease, hyperinfection syndrome, and the 
immunocompromised patients, ivermectin is given daily until symp-
toms cease and stool samples are negative for S stercoralis larvae for 
at least two weeks (1 autoinfection cycle). Diagnosing strongyloidia-
sis early is important, as almost all deaths due to helminths in the 
United States are due to S stercoralis hyperinfection.17 It appears 
that our patient, an immigrant from an endemic area, was a chronic 
carrier of S stercoralis and the recent treatment with steroids precipi-
tated hyperinfection syndrome leading to marked duodenitis. Timely 
diagnosis and providing therapy without delay in our patient most 
likely decreased her mortality as case fatality rate of hyperinfection 
syndrome in patients with diminished cellular immunity is between 
50 and 86%.4,5 
In summary, we presented a case of hyperinfection syndrome with 
Strongyloides stercoralis with improved clinical outcome due to early 
intervention and therapy. Clinicians must have a high suspicion of S 
stercoralis infection, especially in immunocompromised patients, as 
strongyloidiasis is difficult to diagnose and delaying therapy can have 
fatal consequences.
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